Literature DB >> 12682221

CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction.

Ching-Tai Huang1, David L Huso, Zhenbing Lu, Tianhong Wang, Gang Zhou, Eugene P Kennedy, Charles G Drake, David J Morgan, Linda A Sherman, Amy D Higgins, Drew M Pardoll, Adam J Adler.   

Abstract

An important process in the generation of tolerance to peripheral self-Ags is the induction of unresponsiveness in mature specific T cells. Although the end stage of this process, termed anergy, is well defined, the pathway by which naive T cells become anergic remains to be elucidated. Using an in vivo self-tolerance model, we demonstrate that CD4(+) T cells pass through a significant effector stage on their way to an anergic state. This stage is characterized by production of effector cytokines, provision of help for CD8(+) T cells, and induction of in vivo pathology within organs that express cognate Ag. These results suggest that the initial activation stage in T cell tolerance is similar to that seen in memory induction. They also suggest that autoimmune pathology can result during the natural process of tolerance induction rather than requiring that tolerance be broken.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12682221     DOI: 10.4049/jimmunol.170.8.3945

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Authors:  Roberto Mallone; Gerald T Nepom
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

Review 2.  Transplant tolerance: models, concepts and facts.

Authors:  Nicola J Monk; Roseanna E G Hargreaves; Elizabeth Simpson; Julian P Dyson; Stipo Jurcevic
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

3.  Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.

Authors:  Joanne M Fraser; Claire N Janicki; Ben J E Raveney; David J Morgan
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

4.  A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

Authors:  Paul E Zarek; Ching-Tai Huang; Eric R Lutz; Jeanne Kowalski; Maureen R Horton; Joel Linden; Charles G Drake; Jonathan D Powell
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

5.  NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins.

Authors:  Guo N Huang; David L Huso; Samuel Bouyain; Jianchen Tu; Kelly A McCorkell; Michael J May; Yuwen Zhu; Michael Lutz; Samuel Collins; Marlin Dehoff; Shin Kang; Katharine Whartenby; Jonathan Powell; Daniel Leahy; Paul F Worley
Journal:  Science       Date:  2008-01-25       Impact factor: 47.728

6.  Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance.

Authors:  Ian A Parish; Jason Waithman; Gayle M Davey; Gabrielle T Belz; Justine D Mintern; Christian Kurts; Robyn M Sutherland; Francis R Carbone; William R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 7.  Experimental models to investigate the function of dendritic cell subsets: challenges and implications.

Authors:  D G Hancock; T V Guy; E Shklovskaya; B Fazekas de St Groth
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

8.  Cytosolic branched chain aminotransferase (BCATc) regulates mTORC1 signaling and glycolytic metabolism in CD4+ T cells.

Authors:  Elitsa A Ananieva; Chirag H Patel; Charles H Drake; Jonathan D Powell; Susan M Hutson
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

9.  Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.

Authors:  Rachel H McMahan; Jennifer A McWilliams; Kimberly R Jordan; Steven W Dow; Darcy B Wilson; Jill E Slansky
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

10.  Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

Authors:  Sam Collins; Michael A Lutz; Paul E Zarek; Robert A Anders; Gilbert J Kersh; Jonathan D Powell
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.